Related Experiment Video
Updated: Sep 15, 2025

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Meta-analysis of the adjuvant treatment of COPD with Erchen Decoction
Background:
To systematically evaluate the effect of the adjuvant treatment of Chronic obstructive pulmonary disease with Erchen Decoction, exploring its potential in alleviating clinical symptoms and improving patients' quality of life.
Methods:
Two independent evaluators conducted a computerized search of databases including CNKI, Wanfang, VIP, EMBase, Scopus, Web of Science, PubMed, and Cochrane Library. The search aimed to collect randomized controlled trials on Erchen Decoction as an adjuvant treatment for Chronic Obstructive Pulmonary Disease, spanning from the database inception to September 2024, and also traced references within the retrieved literature. Following trial selection and information extraction, they assessed the methodological quality. RevMan 5.3 software was utilized for Meta-analysis, while the Cochrane system evaluated the evidence quality.
Results:
A total of 758 participants were enrolled. Baseline comparisons between the 2 groups showed no statistically significant differences (all P > .05). Post-treatment, the experimental group demonstrated significantly more favorable outcomes for all measured indicators compared to the control group, with all differences reaching statistical significance (P < .05).
Conclusion:
Erchen Decoction exhibits the potential to rapidly alleviate symptoms in chronic obstructive pulmonary disease patients and contribute to the reduction of multiple risk factors. Nevertheless, current evidence is limited by the scarcity of high-quality literature. Therefore, future research should prioritize large-sample, double-blind, randomized controlled trials to provide robust theoretical support for its efficacy.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...